GPX4 and cancer: Thus, measuring the GSH/GSSG ratio in cancer cells can reveal their state of oxidative stress and consequently predict their potential susceptibilities to ROS-inducing and antioxidant-depleting therapies such as GPX4 inhibitors and system XC inhibitors [293].